文献速递糖尿病

HOMA-β低与HOMA-β高受试者中的β细胞去分化

β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究利用13例良性胰腺囊性肿瘤或胰内副脾患者的瘤旁胰腺组织,评估β细胞去分化与体内β细胞功能(HOMA-β)的关联。结果显示去分化比例及标志物Aldh1a3与HOMA-β及功能标志物Glut2、Ucn3呈负相关,HOMA-β低者去分化增加且Bach2表达诱导并与去分化比例正相关。结论强调β细胞去分化参与人类β细胞功能障碍,Bach2可能作为药物靶点。

要点

  • β细胞去分化比例及Aldh1a3与体内HOMA-β及Glut2、Ucn3表达呈负相关。
  • HOMA-β低者胰岛去分化比例增加、Aldh1a3富集、Glut2和Ucn3表达降低。
  • HOMA-β低者胰岛Bach2表达显著诱导,且与β细胞去分化比例正相关。

核心结论

  • β细胞去分化参与人类β细胞功能障碍,HOMA-β低者β细胞Bach2诱导强化其作为β细胞去分化药物靶点的作用。

研究设计与样本

  • 获取13例良性胰腺囊性肿瘤或胰内副脾患者的瘤旁胰腺组织,计算HOMA-β值、激素阴性内分泌细胞数并评估β细胞去分化/功能标志物及新候选因子。

主要发现

  • β细胞去分化比例及去分化标志物Aldh1a3与体内β细胞功能(HOMA-β)及原位β细胞功能标志物Glut2和Ucn3呈负相关。
  • 与HOMA-β高者相比,HOMA-β低者胰岛表现为去分化比例增加、去分化标志物Aldh1a3富集、Glut2和Ucn3表达降低。
  • HOMA-β低者胰岛中基本亮氨酸拉链转录因子2(Bach2)表达显著诱导,并与人类β细胞去分化比例正相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: β-Cell dedifferentiation ratio is increased in type 2 diabetes; but its direct link to in vivo β-cell function in human remains unclear. OBJECTIVE: The present study was designed to investigate whether β-cell dedifferentiation in situ was closely associated with β-cell function in vivo and to identify targets crucial for β-cell dedifferentiation/function in human. METHODS: We acquired homeostasis model assessment of β-cell function (HOMA-β) values, calculated the number of hormone-negative endocrine cells, and evaluated important markers and novel candidates for β-cell dedifferentiation/function on paraneoplastic pancreatic tissues from 13 patients with benign pancreatic cystic neoplasm or intrapancreatic accessory spleen. RESULTS: Both the β-cell dedifferentiation ratio and the dedifferentiation marker (Aldh1a3) were inversely related to in vivo β-cell function (HOMA-β) and in situ β-cell functional markers Glut2 and Ucn3 in humans. Moreover, the islets from HOMA-βlow subjects were manifested as (1) increased β-cell dedifferentiation ratio, (2) enriched dedifferentiation maker Aldh1a3, and (3) lower expression of Glut2 and Ucn3 compared with those from HOMA-βhigh subjects. We found that basic leucine zipper transcription factor 2 (Bach2) expression was significantly induced in islets from HOMA-βlow patients and was positively correlated with the ratio of β-cell dedifferentiation in humans. CONCLUSION: Our findings emphasize the contribution of β-cell dedifferentiation to β-cell dysfunction in humans. Bach2 induction in β-cells with higher frequency of dedifferentiation observed in HOMA-βlow subjects reinforces its distinctive role as a pharmaceutical target of β-cell dedifferentiation for the treatment of people with diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kang F, Zhang Z, Fu H, et al. β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects. J Clin Endocrinol Metab. 2025. PMID: 39133811. doi:10.1210/clinem/dgae538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。